乾眼症模型（2023）

新資訊

本報告分析了全球乾眼市場，並提供了人口在 100 萬或以上的國家中 13 種乾眼相關項目的患病率數據（按年齡組和國家）以及 5 年數據。

目錄

本報告提供了人口超過 100 萬的國家（總共 228 個國家）按國家和年齡組劃分的以下疾病的盛行率數據：

• 臨床前乾眼症
• 乾眼症
• 有乾眼風險的人
• 類風濕性關節炎伴隨乾眼症
• 系統性關節炎伴隨乾眼症
• 狼瘡伴隨乾眼症
• 全身性疾病（不包括伴隨乾眼的乾燥症）
• 眼睛過敏伴隨乾眼症
• 瞼板腺功能障礙合併乾眼症
• 伴隨乾眼症的乾燥症
• 患有乾眼症的隱形眼鏡配戴者
• 與乾眼症相關的全身性藥物

What's New:

Market Scope's "2023 Dry Eye Disease Model" offers extensive country-level prevalence data and five-year forecasts for 13 dry eye-related segments of the population by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients' diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Contents:

The "2023 Dry Eye Disease Model" provides country-level prevalence data by age group for the 228 countries with a population over a million for the following conditions:

• Preclinical dry eye
• Dry eye
• Those at risk for dry eye
• Rheumatoid arthritis with dry eye
• Systemic arthritis with dry eye
• Lupus with dry eye
• Systemic diseases (not including Sjogren's population with dry eye)
• Ocular allergies with dry eye
• Meibomian gland dysfunction with dry eye
• Sjogren's with dry eye
• Contact lens wearer with dry eye
• Systemic drugs with dry eye